Early Study of ReNew Hip Implant for Cartilage Repair
This study is testing a new surgical device called the ReNew Hip Implant for people with hip problems like osteoarthritis (arthritis in the hip joint) or femoroacetabular impingement (a hip joint deformity) that cause cartilage damage. This implant is designed for younger, active individuals (ages 14-64) who have tried other treatments without success and are looking for an alternative to a total hip replacement. The study aims to see how safe and effective the ReNew Hip Implant is by tracking side effects, pain levels, and how well your hip functions over 5 years. We are looking for about 15 participants for this study.
- Study design
- This is an interventional study with a planned enrollment of 15 participants. The phase of the study is not specified, and the status is currently unclear.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for safety and effectiveness at 6 months, 12 months, and 60 months (5 years) after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Early Feasibility Study of Cartilage Defect Repair
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- To establish initial safety (adverse events and device related serious adverse events) and effectiveness (pain and function) of the ReNew Hip Implant6, 12, and 60 months
Incidence rate of all adverse events including general adverse events, procedure related events and device related events. Incidence rate of device-related serious adverse events
- The international Hip Outcome Tool-33 (iHOT-33)6, 12, and 60 months
Difference demonstrated between pre-op and post-op iHOT-33